Catalyst
Slingshot members are tracking this event:
Lexicon (LXRX) Expects to Commence Phase 1 Study of LX9211 in Neuropathic Pain in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LXRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2017
Occurred Source:
http://www.lexpharma.com/media-center/news/653-lexicon-pharmaceuticals-initiates-patient-dosing-in-a-phase-1-study-of-lx9211
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Clinical Study Initiation, Lx9211, Neuropathic Pain
